Neurotoxicity of drugs

Neurotoxicity is not uncommon in use of the drugs in many therapeutic classes. Manifestations of neurotoxicity vary from ototoxicity, visceral neuropathy and neuromuscular blockade (defeat of the peripheral nervous system) to impaired consciousness, nonspecific encephalopathy, seizures and non-convulsive epileptic status (central nervous system damage). The article presents predisposing factors of neurotoxicity, as well as the mechanisms of its development. On the example of neuroactive drugs (anticonvulsants, anesthetics and psychotropic drugs) their effect in the antenatal period and during lactation is examined. In the post-neonatal period antibiotics play an important role in the neurotoxic effect, in particular, ß-lactams and fluoroquinolones.

нейротоксичность, антиконвульсанты, психотропные средства, анестетики, антибиотики, беременность, кормление грудью, фетальный антиконвульсантный синдром, neurotoxicity, anticonvulsants, psychotropic agents, anesthetics, antibiotics, pregnancy, breast-feeding, fetal anticonvulsant syndrome

1. Mira Harrison-Woolrich, Juan Garcia-Quiroga, Jahella Ashton and Peter Herbison “Safety and Usage of Atypical Antipsychotic Medicines in Children” Drug Safety. 2007; 30 (7): 569-79.

2. Tuccori M., Lapi F., Testi A.et al. Statin-Associated Psychiatric Adverse Events. Drug Safety. 2008; 31 (12): 1115-23.

3. Toovey S., Rayner C., Prinssen E.et al. Assessment of Neuropsychiatric Adverse Events in Influenza Patients Treated with Oseltamivir: A Comprehensive Review. Drug Safety. 2008; 31 (12): 1097-1114.

4. Cham S., Koslik H.J., Golomb B.A. Mood, Personality, and Behavior Changes During Treatment with Statins: A Case Series. Drug Safety - Case Reports. December 2016; 3: 1-13.

5. Rezvani M., Finkelstein Y., Verjee Z., Railton C., Koren G. Generalized seizures following topical lidocaine administration during circumcision: establishing causation. Paediatric drugs. 2007; 9 (2): 125-127.

6. Mula M., Sander J. W. Negative Effects of Antiepileptic Drugs on Mood in Patients with Epilepsy. Drug Safety. July 2007; 30: 7: 555-567.

7. James E. Tisdale, Douglas A. Miller Drug induced diseases. American Society of Health-system Pharmacists. Bethesda. 2010; 179-316.

8. Bleggi-Torres L.F., de Medeiros B.C., Werner B. Neuropathological findings after bone marrow transplantation: an autopsy study of 180 cases. Bone Marrow Transplant. 2000; 25 (3): 301.

9. Ikonomidou C.1., Bittigau P., Ishimaru M.J. et al. Ethanol-induced apoptotic neurodegeneration and fetal alcohol syndrome. Science. 2000 Feb 11; 287 (5455): 1056-60.

10. Forcelli P.A. Short- and Long-Term Neurological and Psychiatric Sequelae of Developmental Exposure to Antiepileptic and Anesthetic Drugs. Front Neurol. 2015; 6: 41.

11. Nie Q., Su B., Wei J. et al. Neurological teratogenic effects of antiepileptic drugs during pregnancy. Exp Ther Med. 2016 Oct; 12 (4): 2400-2404. Epub 2016; Aug 29.

12. Пылаева О.А., Мухин К.Ю., Петрухин А.С. Побочные эффекты антиэпилептической терапии. Издательство «Гарант», 2016.

13. Ушкалова Л.В., Ушкалова Е.А. Безопасность психотропных препаратов в период грудного вскармливания. Фарматека. 2013; 1: 55-63.

14. Schmidt D. Anticonvulsants. In: Meylers side-effects of drugs (Dukes M.N.G., ed.). 12th ed. New York: Elsevier Science Publishers BV 1992; 122-43.

15. Клиническая фармакология при беременности. Под редакцией Х.П. Кьюмерле и К. Брендела. «Медицина», 1987; 1: 193-216

16. Gedzelman E., Meador K. Neurological and psychiatric sequelae of developmental exposure to antiepileptic drugs. Front Neurol. 2012; 3: 182. doi: 10.3389/fneur.2012.00182.

17. Turski C.A., Ikonomidou C. Neuropathological sequelae of developmental exposure to antiepileptic and anesthetic drugs. Front Neurol. 2012; 3: 120. doi: 10.3389/fneur.2012.00120.

18. Hanson J. W. Teratogen update: fetal hydantoin effects. Teratology. 1986; 33: 3: 349-353.

19. Bosnjak Z.J., Logan S., Liu Y. Recent Insights Into Molecular Mechanisms of Propofol-Induced Developmental Neurotoxicity: Implications for the Protective Strategies. Anesthesia and analgesia. August 2016; 123 (5): 1286-1296.

20. Каширская Е.И. Клинико-биохимическая оценка и прогнозирование здоровья детей, развивающихся под воздействием психоактивных веществ. Автореферат докторской диссертации. Астрахань, 2010.

21. Ferrajolo C., Capuano A., Trifiro G. Pediatric drug safety surveillance in Italian pharmacovigilance network: an overview of adverse drug reactions in the years 2001- 2012. Expert opinion on drug safety. 2014; 13: Suppl 1: S9-20. Epub2014/08/30.doi: 10.1517/14740338.2014.939581PMID: 25171155.

22. Durand-Maugard C., Lemaire-Hurtel A.-S., Gras-Champel V. Blood and CSF monitoring of cefepime-induced neurotoxicity: Nine case reports. Journal of Antimicrobial Chemotherapy. 2012; 67 (5): 1297-9.

23. Bae Kim K.B., Moon Kim S., Park W. et al. Ceftiaxone-Induced Neurotoxicity: Case Report, Pharmacokinetic Considerations, and Literature Review. Journal of Korean medical science. 2012; 27 (9): 1120-3.

24. Падейская Е.Н., Яковлев С.В. Антимикробные препараты группы фторхинолонов в клинической практике». Логета». М.: 1998.

25. Яковлев В.П., Падейская Е.Н., Яковлев С.В. Ципрофлоксацин в клинической практике. М.: 2000.

26. Rama K Maganti. Neurotoxic effects associated with antibiotic use: Management considerations. British Journal of Clinical Pharmacology. 2011; 72 (3): 381-93.

27. Постников С.С., Костылева М.Н., Брюсов Г.П. Случай синдрома инфузии пропофола у ребенка 10 лет. Безопасность и риск фармакотерапии. 2016; 4: 5-10.

28. Renbarger J.L., McCammack K.C., Rouse C.E., Hall S.D. Effect of race on vincristine associated neurotoxicity in pediatric acute lymphoblastic leukemia patients. Pediatric Blood and Cancer. 2008 April; 50 (4): 769-71. PMID: 18085684.